SKYE vs. OPAD

Last updated Jun 9, 2026

SKYE (Skye Bioscience, Inc) and OPAD (Offerpad Solutions Inc.) are both stocks. SKYE operates in Biotechnology (Healthcare), while OPAD operates in Real Estate - Services (Real Estate). Over the past 5 years, SKYE returned -54.71%/yr vs -67.51%/yr for OPAD. At a 0.11 correlation, their price movements are largely independent.

Performance

SKYE vs. OPAD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Skye Bioscience, Inc (SKYE) and Offerpad Solutions Inc. (OPAD). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, SKYE achieves a 2.71% return, which is significantly higher than OPAD's -55.36% return.

SKYE

• 1D: 5.02%
• 1M: -10.75%
• YTD: 2.71%
• 6M: -36.36%
• 1Y: -68.31%
• 3Y*: -41.13%
• 5Y*: -54.71%
• 10Y*: -40.24%

OPAD

• 1D: -12.51%
• 1M: -19.39%
• YTD: -55.36%
• 6M: -70.81%
• 1Y: -52.20%
• 3Y*: -61.68%
• 5Y*: -67.51%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

SKYE vs. OPAD - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
SKYE Skye Bioscience, Inc	2.71%	-73.51%	4.04%	-32.84%	-68.85%	30.00%	33.33%
OPAD Offerpad Solutions Inc.	-55.36%	-57.54%	-72.20%	48.39%	-92.80%	-41.82%	0.24%

Correlation

The correlation between SKYE and OPAD is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.14
Correlation (3Y) Calculated over the trailing 3-year period	0.10
Correlation (5Y) Calculated over the trailing 5-year period	0.10
Correlation (All Time) Calculated using the full available price history since Dec 11, 2020	0.11

Fundamentals

Market Cap SKYE : $30.55M OPAD : $24.95M
EPS SKYE : -$1.45 OPAD : -$1.16
PB Ratio SKYE : 3.39 OPAD : 0.54
Total Revenue (TTM) SKYE : $0.00 OPAD : $487.19M
Gross Profit (TTM) SKYE : -$180.01K OPAD : $37.09M
EBITDA (TTM) SKYE : $10.92M OPAD : -$29.30M

Return for Risk

SKYE vs. OPAD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SKYE

SKYE Risk / Return Rank: 19
SKYE Sharpe Ratio Rank: 16
SKYE Sortino Ratio Rank: 22
SKYE Omega Ratio Rank: 21
SKYE Calmar Ratio Rank: 12
SKYE Martin Ratio Rank: 21

OPAD

OPAD Risk / Return Rank: 38
OPAD Sharpe Ratio Rank: 32
OPAD Sortino Ratio Rank: 56
OPAD Omega Ratio Rank: 51
OPAD Calmar Ratio Rank: 22
OPAD Martin Ratio Rank: 28

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SKYE vs. OPAD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Skye Bioscience, Inc (SKYE) and Offerpad Solutions Inc. (OPAD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SKYE	OPAD	Difference
Sharpe ratio: Return per unit of total volatility	-0.59	-0.25	-0.35
Sortino ratio: Return per unit of downside risk	-0.44	1.01	-1.45
Omega ratio: Gain probability vs. loss probability	0.94	1.11	-0.17
Calmar ratio: Return relative to maximum drawdown	-0.78	-0.57	-0.21
Martin ratio: Return relative to average drawdown	-1.04	-0.77	-0.27
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

SKYE vs. OPAD - Sharpe Ratio Comparison

The current SKYE Sharpe Ratio is -0.59, which is lower than the OPAD Sharpe Ratio of -0.25. The chart below compares the historical Sharpe Ratios of SKYE and OPAD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	SKYE	OPAD	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.59	-0.25	-0.35
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.42	-0.52	+0.10
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.29	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.36	-0.51	+0.16

Drawdowns

SKYE vs. OPAD - Drawdown Comparison

The maximum SKYE drawdown since its inception was -99.96%, roughly equal to the maximum OPAD drawdown of -99.82%. Use the drawdown chart below to compare losses from any high point for SKYE and OPAD.

Drawdown Indicators

	SKYE	OPAD	Difference
Max Drawdown Largest peak-to-trough decline	-99.96%	-99.82%	-0.14%
Max Drawdown (1Y) Largest decline over 1 year	-87.85%	-91.33%	+3.48%
Max Drawdown (3Y) Largest decline over 3 years	-96.79%	-96.35%	-0.44%
Max Drawdown (5Y) Largest decline over 5 years	-98.66%	-99.82%	+1.16%
Max Drawdown (10Y) Largest decline over 10 years	-99.83%	—	—
Current Drawdown Current decline from peak	-99.94%	-99.82%	-0.12%
Average Drawdown Average peak-to-trough decline	-94.95%	-82.08%	-12.87%
Ulcer Index Depth and duration of drawdowns from previous peaks	65.76%	68.07%	-2.31%

Volatility

SKYE vs. OPAD - Volatility Comparison

The current volatility for Skye Bioscience, Inc (SKYE) is 28.64%, while Offerpad Solutions Inc. (OPAD) has a volatility of 30.56%. This indicates that SKYE experiences smaller price fluctuations and is considered to be less risky than OPAD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SKYE	OPAD	Difference
Volatility (1M) Calculated over the trailing 1-month period	28.64%	30.56%	-1.92%
Volatility (6M) Calculated over the trailing 6-month period	63.38%	75.65%	-12.27%
Volatility (1Y) Calculated over the trailing 1-year period	115.33%	210.71%	-95.38%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	130.81%	131.29%	-0.48%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	137.31%	125.52%	+11.79%

Dividends

SKYE vs. OPAD - Dividend Comparison

Neither SKYE nor OPAD has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both SKYE and OPAD in my portfolio?

SKYE and OPAD have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, SKYE or OPAD?

OPAD has higher volatility (30.56%) compared to SKYE (28.64%). In terms of maximum drawdown, SKYE dropped -99.96% vs OPAD's -99.82%.

Which has better risk-adjusted returns?

OPAD currently has the higher Sharpe Ratio (-0.25 vs -0.59), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.